| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARCH Venture Fund XII, L.P. | 21% | $61,805,320 | 33,958,967 | Kristina Burow | 27 Oct 2025 | |||
| K2 HealthVentures Equity Trust LLC | 6.6% | $12,081,149 | 11,397,310 | K2 HealthVentures Equity Trust LLC | 09 May 2025 | |||
| BERNS PAUL L | 5.1% | $6,334,229 | 8,226,272 | Paul L Berns | 31 Dec 2024 | |||
| FMR LLC | 2.2% | $2,692,163 | 3,496,316 | FMR LLC | 31 Mar 2025 |
As of 30 Sep 2025, 92 institutional investors reported holding 50,719,734 shares of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA). This represents 31% of the company’s total 164,052,981 outstanding shares.
The largest institutional shareholders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SOFTBANK GROUP CORP. | 4% | 6,541,190 | 0% | 0.05% | $11,904,966 |
| MIC Capital Management UK LLP | 2.7% | 4,460,700 | 0% | 1.6% | $8,118,474 |
| Siren, L.L.C. | 2.7% | 4,358,283 | 0% | 0.31% | $7,932,075 |
| VANGUARD GROUP INC | 2.5% | 4,049,167 | -15% | 0% | $7,369,484 |
| FMR LLC | 2.1% | 3,501,732 | -0.03% | 0% | $6,373,152 |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 2% | 3,309,123 | 0% | 0.07% | $6,022,604 |
| ICONIQ Capital, LLC | 1.6% | 2,559,090 | 0% | 0.06% | $4,657,544 |
| Lunate Capital Ltd | 1.3% | 2,124,143 | 0% | 1.8% | $3,865,940 |
| MILLENNIUM MANAGEMENT LLC | 1.2% | 2,008,248 | +63% | 0% | $3,655,011 |
| T. Rowe Price Investment Management, Inc. | 1.2% | 1,938,100 | -7.8% | 0% | $3,528,000 |
| JOHNSON & JOHNSON | 1.1% | 1,849,445 | 0% | 0.67% | $3,365,990 |
| BlackRock, Inc. | 1.1% | 1,815,930 | -37% | 0% | $3,304,992 |
| TANG CAPITAL MANAGEMENT LLC | 0.85% | 1,400,000 | 0% | 0.1% | $2,548,000 |
| RENAISSANCE TECHNOLOGIES LLC | 0.71% | 1,163,976 | -19% | 0% | $2,118,436 |
| TWO SIGMA ADVISERS, LP | 0.6% | 977,000 | -21% | 0% | $1,778,140 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.59% | 968,928 | +5.7% | 0% | $1,764,252 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.51% | 830,818 | 0.01% | $1,512,089 | |
| AlphaCore Capital LLC | 0.39% | 638,784 | +89% | 0.04% | $1,162,587 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.31% | 512,939 | +16% | 0% | $933,549 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.26% | 424,244 | +57% | 0% | $772,124 |
| STATE STREET CORP | 0.24% | 388,919 | +11% | 0% | $707,833 |
| GOLDMAN SACHS GROUP INC | 0.23% | 377,374 | -25% | 0% | $686,820 |
| FEDERATED HERMES, INC. | 0.19% | 314,119 | 0% | 0% | $571,697 |
| TWO SIGMA INVESTMENTS, LP | 0.18% | 299,814 | -49% | 0% | $545,661 |
| Cerity Partners LLC | 0.18% | 288,515 | -11% | 0% | $525,097 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 3,577,065 | $6,402,670 | -$53,131 | $1.79 | 7 |
| 2025 Q3 | 50,719,734 | $92,298,641 | -$7,645,546 | $1.82 | 92 |
| 2025 Q2 | 56,105,109 | $41,177,547 | -$6,520,439 | $0.73 | 96 |
| 2025 Q1 | 65,233,736 | $65,235,367 | -$163,396,114 | $1.00 | 111 |
| 2024 Q4 | 80,333,766 | $851,575,296 | +$93,329,557 | $10.60 | 132 |
| 2024 Q3 | 68,678,182 | $907,013,068 | +$21,361,695 | $13.21 | 103 |
| 2024 Q2 | 63,827,298 | $627,414,966 | +$100,142,866 | $9.83 | 92 |
| 2024 Q1 | 52,696,596 | $725,374,900 | +$114,726,209 | $13.75 | 86 |
| 2023 Q4 | 43,747,888 | $744,815,306 | +$130,275,365 | $17.05 | 60 |
| 2023 Q3 | 36,353,167 | $512,042,809 | +$512,042,809 | $14.11 | 38 |